This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

3 Biotech Stocks Spiking on Big Volume

Stocks in this article: IMGN ECYT ICPT

ImmunoGen

ImmunoGen ( IMGN) is focused on the development of therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies and small molecule cytotoxic or cell-killing, agents. This stock is trading up 3.4% at $17.93 in recent trading.

Today's Volume: 553,000
Average Volume: 756,459
Volume % Change: 50%

>>5 Stocks That Have Yet to Recover From 2008

From a technical perspective, IMGN is trending higher here right above its 50-day moving average of $16.53 with decent upside volume. This stock has been uptrending notably for the last few weeks, with shares moving higher from its low of $15.18 to its intraday high of $18.33. During that move, shares of IMGN have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of IMGN within range of triggering a major breakout trade. That trade will hit if IMGN manages to take out its 52-week high at $18.83 with high volume.

Traders should now look for long-biased trades in IMGN as long as it's trending above its 50-day at $16.53, and then once it sustains a move or close above today's intraday high of $18.33 and then above its 52-week high at $18.83 with volume that hits near or above 756,459 shares. If that breakout triggers soon, then IMGN will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $20 to $25.

Intercept Pharmaceuticals

Intercept Pharmaceuticals ( ICPT) is a development-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver disease utilizing its proprietary bile acid chemistry. This stock is trading up 0.77% at $44.28 in recent trading.

Today's Volume: 105,000
Average Volume: 75,759
Volume % Change: 100%

>>5 Rocket Stocks to Buy for July

From a technical perspective, is trending modestly higher here right above some key near-term support at $43 with above-average volume. This stock has been uptrending incredibly strong for the last month, with shares soaring higher from its low of $30.73 to its recent high of $45. During that uptrend, shares of ICPT have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ICPT within range of triggering a major breakout trade, which will hit if ICPT manages to take out its all-time high at $45 with high volume.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs